Genomics

Dataset Information

40

The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 Acute Myelogenous Leukemia


ABSTRACT: Acute Myeloid Leukemia (AML) with MLL gene rearrangements demonstrate unique gene expression profiles driven by MLL-fusion proteins. Here, we identify the circadian clock transcription factor SHARP1 as a novel oncogenic target in MLL-AF6 AML, which has the worst prognosis among all subtypes of MLL rearranged AMLs. SHARP1 is expressed solely in MLL-AF6 AML, and its expression is regulated directly by MLL-AF6 / DOT1L. Suppression of SHARP1 induces robust apoptosis of human MLL-AF6 AML cells. Genetic deletion in mice delays the development of leukemia and attenuated leukemia-initiating potential, while sparing normal hematopoiesis. Mechanistically, SHARP1 binds to transcriptionally active chromatin across the genome and activates genes critical for cell survival as well as key oncogenic targets of MLL-AF6. Our findings demonstrate the unique oncogenic role for SHARP1 in MLL-AF6 AML. Overall design: ChIP-seq and RNA-seq using ML-2 cells. ChIP-seq using SHI1 cells.

REANALYSIS of: GSE83671

INSTRUMENT(S): Illumina HiSeq 2000 (Homo sapiens)

SUBMITTER: Jia Li 

PROVIDER: GSE95511 | GEO | 2018-04-26

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
GSE95511_RAW.tar Raw
filelist.txt Txt
Items per page:
1 - 2 of 2
altmetric image

Publications


Acute Myeloid Leukemia (AML) with MLL gene rearrangements demonstrate unique gene expression profiles driven by MLL-fusion proteins. Here, we identify the circadian clock transcription factor SHARP1 as a novel oncogenic target in MLL-AF6 AML, which has the worst prognosis among all subtypes of MLL-rearranged AMLs. SHARP1 is expressed solely in MLL-AF6 AML, and its expression is regulated directly by MLL-AF6/DOT1L. Suppression of SHARP1 induces robust apoptosis of human MLL-AF6 AML cells. Genetic  ...[more]

Similar Datasets

1000-01-01 | S-EPMC5915391 | BioStudies
2013-01-01 | S-EPMC3612861 | BioStudies
1000-01-01 | S-EPMC2904581 | BioStudies
2017-01-01 | S-EPMC5653649 | BioStudies
2020-01-01 | S-EPMC7509857 | BioStudies
2012-01-01 | S-EPMC3382941 | BioStudies
2008-01-01 | S-EPMC2936245 | BioStudies
2020-01-01 | S-EPMC6947934 | BioStudies
2014-01-01 | S-EPMC4017259 | BioStudies
2016-01-01 | S-EPMC4809417 | BioStudies